The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Control of hepatitis C: a medicinal chemistry perspective.EBI
University of Wollongong
Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors.EBI
Imim/Universitat Pompeu Fabra
Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease.EBI
Irbm, Mrl Rome
Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides.EBI
Shire Biochem
Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.EBI
Shire Biochem
Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.EBI
Shire Biochem
Glycine alpha-ketoamides as HCV NS3 protease inhibitors.EBI
Pharmaceutical Research Institute
Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease.EBI
Irbm, Mrl Rome
Identification and Biological Evaluation of a Series of 1H-Benzo[de]isoquinoline-1,3(2H)-diones as Hepatitis C Virus NS5B Polymerase Inhibitors.BDB
Irbm, Mrl Rome